mtiRL enhances the binding of ANXA2 to Yes1 and facilitates the phosphorylation of ANXA2 at Tyr24, thereby stimulating the proliferation and metastasis of bladder cancer cells. This evidence concerns the gene ANXA2 and urinary bladder carcinoma.